Industry News
Coridon's herpes vaccine trial progressing well
Coridon, Allied Healthcare's (ASX:AHZ) 50.1%-owned subsidiary, said no safety issues were raised during dosing of the first two cohorts in a phase I study of its herpes vaccine and treatment. [ + ]
ACIP releases options paper on innovation patents
The Advisory Council on Intellectual Property (ACIP) has just released an Options Paper for its Review of the Innovation Patent System. ACIP is seeking stakeholder comments on policy issues that address the full range of possibilities for the innovation patent system. [ + ]
Telesso to raise $6.5m to fund acne drug trial
Shell company Telesso (ASX:TEO) aims to raise up to $6.5m to help support its plan to acquire Mimetica, take on the company's name and fund phase II trials for Mimetica's acne drug candidate. [ + ]
Alchemia narrows FY13 loss by $10.3m
Revenue from fonadaparinux sales and R&D Tax Incentive benefits helped Alchemia (ASX:ACL) reduce its FY13 loss by more than 68% to $4.8m. [ + ]
GTG cleared to sell BREVAGen in NY
Genetic Technologies (ASX:GTG) has received the approval required to launch breast cancer test BREVAGen in NY, meaning the company can now provide the product in all 50 US states. [ + ]
Butterfly inspires beam-splitting nanotechnology
Inspired by coiled nanostructures in butterfly wings, researchers have developed a photonic crystal that could steer optical communications technologies in a faster direction. [ + ]
AusBiotech responds to Qld review of its Gene Technology Act
Amid 48 submissions, AusBiotech responded to the Queensland 'Review of the Gene Technology Act 2001 (Qld)', seeking support for a nationally consistent scheme for gene technology regulation. [ + ]
Optical fibres enable a bright future for nanocrystal measurement
A team of researchers from Macquarie University, the University of Adelaide and Peking University has discovered a way to measure the world's most sensitive nanoparticle from a distance using light. The research has been published in the journal Nature Nanotechnology. [ + ]
Nanotechnology microscope to help develop cheap plastic solar cells
Queensland University of Technology (QUT) has recently installed one of the world's most powerful nanotechnology microscopes. The only one if its kind in Australia, the Zeiss Orion NanoFab enables researchers to examine natural or manmade structures in incredible detail and will create new insights wherever it is applied. [ + ]
Agenix teams with Arrayjet on POCT project
Agenix (ASX:AGX) and Scotland's Arrayjet have teamed up to develop a platform capable of conducting multiplexed affinity-based assays. [ + ]
T cell researcher receives L'Oréal Fellowship
Three young female scientists were this week awarded the 2013 L'Oréal for Women in Science Fellowships. One such scientist was Dr Misty Jenkins, who was recognised for her work in understanding whether cancer cells emit a 'distress call' when under lethal attack from healthy T cells. [ + ]
Mesoblast bolsters cash position in FY13
Mesoblast's (ASX:MSB) recent $170m capital raising allowed the company to close out FY13 with total available funds of $315m. [ + ]
Measuring brain volume loss
The Sydney Neuroimaging Analysis Centre, located with the Brain and Mind Research Institute in Sydney, is now home to some sophisticated neuroimaging technology previously unavailable in Australia. [ + ]
Call for nominations to the board of directors of AusBiotech
Further to the notice of the forthcoming election for the board of directors of AusBiotech for 2013-14, nominations are now open for eligible AusBiotech members. [ + ]
A new super-weight baby for the periodic table
Ununpentium is the interim name for the latest super-weight to have its existence confirmed (but not yet acknowledged) - element 115. [ + ]